Medical doctors and HIV researches Mari Kitahata and Jonathan Sterne presented the results of several studies addressing this complex question at the 16th Annual Conference on Retroviruses and Opportunistic Infections, which was held on February 9, 2009.
Recently updated U.S. guidelines recommend initiating HAART (highly active antiretroviral therapy) in all asymptomatic HIV positive patients with a CD4 count of less than 350. Kitahata and Stern, in this presentation/interview, review emerging data that indicates that introducing therapy even earlier in HIV disease, at CD4 counts greater than 500, could significantly prolong an individual’s survival.
To read the complete transcript, follow this URL: http://www.thebody.com/content/confs/croi2009/art50496.html
I began with AZT only at 29 in 1988,it was all we had then.
21 years later my Viral Load remains >50 and I have more
than 500 helper t-cells.
I believe the sooner the better.